<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ingm on BEHIND-MS</title>
    <link>https://www.behind-ms.eu/en/tags/ingm/</link>
    <description>Recent content in Ingm on BEHIND-MS</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Wed, 15 May 2024 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.behind-ms.eu/en/tags/ingm/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Fondazione Istituto Nazionale di Genetica Molecolare, Università degli studi di Milano, Dipartimento di Scienze Cliniche e di Comunità</title>
      <link>https://www.behind-ms.eu/en/teams/ingm/</link>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/ingm/</guid>
      <description>&lt;p&gt;&lt;img src=&#34;https://www.behind-ms.eu/img/teams/INGM-team.jpg&#34; alt=&#34;INGM Team&#34;&gt;&lt;/p&gt;&#xA;&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project&lt;/h2&gt;&#xA;&lt;p&gt;We will monitor polyclonal, and virus-specific regulatory and cytotoxic effector T-cells in patients and humanised mice, including cells recognising potentially MS-associated EBV-derived epitopes. In addition, we will try to identify virus-derived factors that induce adaptive regulatory T-cells from pro-inflammatory precursors.&lt;/p&gt;&#xA;&lt;h2 id=&#34;team-members&#34;&gt;Team Members&lt;/h2&gt;&#xA;&lt;h3 id=&#34;jens-geginat---pi&#34;&gt;Jens Geginat - PI&lt;/h3&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://www.behind-ms.eu/img/teams/Jens-Geginat.jpg&#34; alt=&#34;Jens Geginat&#34;&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;em&gt;From a recent congress in Davos (WIRM)&lt;/em&gt;&#xA;Jens Geginat obtained his Diploma in Biochemistry as well as his Ph.D at the Department of Chemistry of the Free University of Berlin in 1994 and 1999, respectively. He performed the experimental work of his Diploma at the Istituto Tumori at Genoa in Italy, and of his Ph.D at the Scientific Institute of San Raffaele in Milan, Italy. He then joined the lab of A. Lanzavecchia at the Basel Institute for Immunology in Switzerland, and moved in 2000 to the Institute for Research in Biomedicine in southern Switzerland.  In 2006, he was selected for a Junior Group Leader position at the Charité Medicine University and the German Rheumatology Research Centre headed by A. Radbruch in Berlin, Germany. Since 2009 he works as Principal Investigator at the Istituto Nazionale di Genetica Molecolare. In 2020 he was appointed also as Assistant Professor for General Pathology at the University of Milan. His research interest is mainly focussed on the role of T-cells that produce the anti-inflammatory cytokine IL-10 in a wide range of pathologies.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
